Inflammaging and Japan's Longevity Evidence: What the Chronic Low-Grade Inflammation Research Shows

Research Observational

Jul 7, 2026 11 min read

Affiliate disclosure: Some links in this article are affiliate links. We may earn a commission at no additional cost to you.

Medical disclaimer: This article is for informational purposes only. It is not medical advice, diagnosis, or treatment. Not medical advice. Consult a qualified healthcare professional before changing your diet, supplement regimen, or any health-related practice.

The term “inflammaging” was introduced in 2000 by immunologist Claudio Franceschi and colleagues in a paper published in Annals of the New York Academy of Sciences. It describes a specific pattern: the gradual rise of low-level, chronic, sterile systemic inflammation across the decades of human aging, measurable in circulating biomarkers such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), and associated in observational research with cardiovascular events, cognitive decline, and sarcopenia. Japanese population research intersects with this concept in several places — through dietary factor studies and through biomarker data collected from very old cohorts. This article reviews what that evidence actually says, where it is observational and correlational, and where it is preliminary or contested.

TL;DR

Inflammaging describes the age-associated rise in chronic, low-grade systemic inflammation, measured by biomarkers including CRP, IL-6, and TNF-α; it is associated in observational data with multiple age-related conditions, though the direction of causality in individual disease associations is debated
Japanese centenarian cohorts show lower circulating inflammatory biomarkers compared to typical elderly adults, documented in both the Keio super-centenarian study and data adjacent to the Okinawa Centenarian Study; whether this reflects dietary effects, genetic factors, survivor selection, or some combination is unresolved
EPA and DHA from oily fish — consumed regularly in Japan’s longevity-associated prefectures — are among the better-evidenced dietary factors for modulating inflammatory biomarkers; the JPHC cohort data on fish consumption and cardiovascular mortality provides the strongest Japanese population anchor for this relationship
Soy isoflavones (miso, natto, edamame) and green tea catechins have shown directional associations with inflammatory markers in several Japanese and cross-cultural studies, but effect sizes are modest and findings are not consistently replicated across populations
The practical framing the evidence supports is dietary pattern, not supplement-based “anti-inflammatory” interventions, which carry a thinner evidence base for clinical outcomes

What inflammaging actually describes

Franceschi’s 2000 formulation drew on a paradox in immunogerontology: very old people are not immunologically depleted in the way simple wear-and-tear models predict. Many centenarians show preserved adaptive immune function alongside measurably elevated pro-inflammatory cytokine levels. Franceschi framed this as a compensatory and cumulative process — lifelong activation of innate immune surveillance responding to cellular debris, persistent low-level microbial exposure, accumulating senescent cells, and environmental inputs produces a chronic inflammatory background that rises with age even in the absence of overt infection or injury.

A 2019 review by Franceschi, Garagnani, and Vitale in Nature Reviews Immunology refined this framework. They distinguished inflammaging as a systemic background condition from acute inflammatory responses and proposed that it reflects a combination of genetic predisposition, lifetime microbial exposure history (what they called the “immunobiography”), and accumulated senescent cell burden rather than a single mechanism. This distinction matters for reading dietary research: a dietary factor that modestly shifts a circulating biomarker is interacting with a process that is multi-causal and decades in development.

For the purposes of reading the Japanese population literature, three biomarkers appear most frequently:

CRP (C-reactive protein) is an acute-phase protein produced by the liver in response to IL-6 signaling; high-sensitivity CRP (hsCRP) measures the low-level elevations relevant to inflammaging research rather than the large spikes associated with acute infection or tissue injury. IL-6 is a pro-inflammatory cytokine produced by multiple cell types; chronically elevated IL-6 in aging is associated in observational data with muscle loss and frailty markers. TNF-α is a cytokine with both pro- and anti-inflammatory roles; its association with age-related inflammatory burden is directionally consistent across cohort data but more variable across measurement conditions than IL-6 or CRP.

Japanese centenarian data on inflammatory biomarkers

The most relevant Japanese population data for inflammaging research comes from two cohort programs.

The Keio super-centenarian study — the same cohort that documented unusual gut microbiome profiles in Japanese individuals aged 110 and older in a 2021 Nature Metabolism paper — also measured circulating inflammatory markers. The super-centenarian group showed lower serum IL-6 and hsCRP relative to centenarian and elderly adult comparators. This pattern is not unique to Japanese populations: centenarian cohorts in Italy, Denmark, and Portugal have similarly documented lower chronic inflammatory burden in very long-lived individuals relative to typical elderly comparators. What the Japanese data adds is a population with unusual centenarian density and a lifetime dietary background consistently different from European cohorts, allowing the dietary hypothesis to be considered — though not tested causally with available data.

The survivor selection caveat applies structurally. Only people who reached 110 and older are included; whether lower inflammatory biomarkers contributed to their survival, or whether those biomarker profiles reflect the same biological configuration that enabled extreme old age through other pathways, cannot be separated with observational data from a cohort defined by survival itself.

The Okinawa Centenarian Study, led by Bradley Willcox, D. Craig Willcox, and Makoto Suzuki, has not produced a standalone inflammatory biomarker analysis with the same prominence as the Keio study, but published work from the program documents that the centenarian cohort shows favorable cardiovascular and vascular inflammation profiles relative to reference populations. An important caveat here is cohort specificity: the Okinawan centenarians documented in the research grew up in a dietary context centered on sweet potato, minimal animal protein, and locally grown vegetables — a dietary pattern no longer representative of the current Okinawan population, which has followed national trends toward Western dietary patterns and has correspondingly declined in male longevity rankings.

Dietary factors the inflammation literature has examined in Japanese contexts

Three dietary component categories appear frequently in Japanese-population inflammation research.

EPA and DHA from oily fish. The omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) have the most substantial evidence base for inflammatory biomarker modulation of any single dietary factor examined in this literature. The proposed mechanism — EPA and DHA competing with arachidonic acid for cyclooxygenase and lipoxygenase enzyme activity, reducing pro-inflammatory eicosanoid production — is reasonably well-characterized in human biochemistry. Multiple randomized controlled trials of fish oil supplementation show reductions in circulating IL-6, TNF-α, and hsCRP, though effect sizes are dose-dependent and not all trials reach statistical significance.

The Japanese connection to this evidence runs through the JPHC (Japan Public Health Center-based Prospective) cohort, which has published data showing that higher dietary fish consumption — at levels above roughly 60 grams per day — is associated with lower fatal coronary event risk. Kyotango City in Kyoto Prefecture, which carries Japan’s highest documented centenarian density (approximately five times the national average in a city of around 50,000 residents), has dietary survey data showing regular consumption of Sea of Japan oily fish — mackerel, sardines, yellowtail — as a dominant feature of the centenarian and near-centenarian dietary pattern. The association between this dietary fish consumption and longevity outcomes is observational; fish consumption in this population is correlated with many other dietary and lifestyle factors, including subsistence gardening and dense social networks, that have not been independently measured.

For those not eating regular oily fish, EPA and DHA supplementation is the most evidence-grounded proxy in this literature. Products with published third-party purity testing from brands including Carlson and Nordic Naturals are available on Amazon. Algae-derived EPA and DHA — the original marine source before fish bioconcentration — is available at comparable concentrations from Deva and similar brands for those avoiding fish-derived products: Amazon.

Soy isoflavones. The isoflavones in fermented soy foods — genistein and daidzein in miso, tofu, and edamame; equol, a gut-metabolized daidzein derivative produced in roughly 50% of adults who carry the relevant gut bacterial populations — have shown associations with inflammatory biomarker levels in several studies. A published analysis using JPHC cohort data found that isoflavone intake was inversely associated with circulating IL-6 and TNF-α in a dose-dependent pattern in women; the association was weaker and less consistent in men. The finding is observational and isoflavone intake in the Japanese cohort is correlated with adherence to a traditional dietary pattern broadly, not with soy consumption in isolation.

Natto adds a component not prominently featured in other fermented soy foods: polyamines, particularly spermine and spermidine. Spermidine has attracted research attention as an autophagy inducer and has been studied in aged animal models for effects on cellular senescence markers. Epidemiological analyses have linked higher dietary polyamine intake — in which natto is a concentrated source — with lower cardiovascular mortality in observational data. The evidence in humans remains preliminary; natto’s polyamine content makes it a plausible candidate for inclusion in inflammaging research, not a demonstrated intervention target.

Green tea catechins. EGCG (epigallocatechin gallate), the principal catechin in green tea, has been studied extensively in cell culture and animal models for its capacity to inhibit NF-κB signaling, a transcription factor regulating many pro-inflammatory gene targets. Human clinical trial data on EGCG and inflammatory biomarkers is less consistent than the preclinical literature would suggest. Several small trials have found reductions in hsCRP with high-dose catechin supplementation; a meta-analysis of green tea intervention studies published in 2020 found a statistically significant but modest reduction in CRP and IL-6 across the pooled trial data, with high between-study heterogeneity that limits confidence in the pooled estimate.

The Ohsaki cohort — a large prospective study in Miyagi Prefecture — has published data associating higher green tea consumption with lower all-cause mortality across multiple analytic approaches. The inflammatory mechanism is one of several proposed explanations. Whether the mortality association in this cohort is carried by catechins specifically, or by dietary and lifestyle factors correlated with regular green tea-drinking behavior, is not established. For sourcing, Ippodo and Marukyu Koyamaen both export Japanese green tea internationally; Amazon carries options.

What the evidence does not support

Two framings that circulate in health coverage of inflammaging are not supported by the literature reviewed here.

That specific foods or supplements “reduce inflammation” in a clinically meaningful sense. The dietary factor associations described above are at the level of circulating biomarker concentrations in observational populations, or in controlled trials measuring surrogate endpoints rather than disease outcomes. The inferential step from “EPA is associated with lower IL-6 in cohort data” to “taking omega-3 supplements will reduce your inflammatory age-related disease risk” is longer than health journalism typically makes it look. The omega-3 cardiovascular outcome trials — ASCEND and VITAL, two large randomized trials — showed smaller effects on hard endpoints than cohort-association studies suggested, a pattern common in nutrition research when observational associations are tested in intervention designs.

That Japan’s longevity outcomes are primarily explained by lower inflammaging. Japan’s adult life expectancy — consistently among the highest globally in WHO and OECD data — reflects multiple intersecting factors: a healthcare system with broad access to preventive screening and chronic disease management, dietary patterns historically lower in processed food and saturated fat, low rates of obesity, high social engagement, and genetic population characteristics that remain incompletely characterized. The inflammaging research on Japanese populations provides a window into one biological axis of aging; it does not provide a single causal account of Japan’s longevity outcomes.

Practical framing

The evidence base most relevant to inflammaging is consistent with emphasizing dietary pattern over individual supplements. The dietary patterns associated with lower chronic inflammatory burden in Japanese cohort data — regular oily fish, substantial plant food variety including sea vegetables and fermented soy, limited processed food intake — are patterns, not prescriptions derived from controlled trials.

For those researching supplements specifically: fish oil is the best-evidenced single-item supplement in the inflammatory biomarker literature. The case for green tea extract and soy isoflavone supplements is weaker than for dietary sources because the cohort observations are built on food consumption patterns, not isolated supplement use. Anyone with a diagnosed inflammatory condition, cardiovascular history, or autoimmune context should discuss dietary modifications with a qualified clinician before making changes based on population-level observational findings.

For accessible coverage of the broader geroscience context including inflammaging, Valter Longo’s The Longevity Diet and comparable research-grounded titles are available on Amazon. For the primary scientific literature, Franceschi’s 2000 and 2019 review papers are the entry points — both are publicly accessible through PubMed.

Japanese Longevity Supplements (Science-Backed)

Products related to topics covered in this article — not a purchase recommendation.

View on Amazon →

Not a purchase recommendation — for research reference only